CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China

CBC Group Singapore China Saudi Arabia Qatar Lebanon Germany Kuwait Oman Switzerland Yemen Syria Iraq

CBC Group and Mubadala acquire UCB's mature neurology and allergy business in China for US$680 million.New company is named NeuroGen Pharma, led by an experienced management team with a strong track record in the biopharma industry.Strategic acquisition under CBC's buyout strategy expected to drive significant value creation and positive patient outcomes through CBC's proven investor-operator approach and solution.View original content:https://www.prnewswire.co.uk/news-releases/cbc-group-completes-strategic-acquisition-of-ucbs-mature-product-portfolio-in-china-302319018.html